Serum anti-Müller hormone as a predictor of polycystic ovary syndrome in women of reproductive age – BMC Women’s Health

Michelmore KF, Balen AH, Dunger DB, Vessey MP. Polycystic ovaries and associated clinical and biochemical features in young women. Clin Endocrinol. 1999;51(6):779-86. https://doi.org/10.1046/j.1365-2265.1999.00886.x.

CAS article Google Scholar

Koivunen R, Laatikainen T, Tomas C, Huhtaniemi I, Tapanainen J, Martikainen H. The prevalence of polycystic ovaries in healthy women. Acta Obstet Gynaecol Scan. 1999, 78(2):137-41.

CAS PubMed Google Scholar

Farquhar CM, Birdsall M, Manning P, Mitchell JM, France JT. The prevalence of polycystic ovaries on ultrasound in a population of randomly selected women. Aust New Zeal J Obstet Gynaecol. 1994;34(1):67-72. https://doi.org/10.1111/j.1479-828x.1994.tb01041.x.

CAS article Google Scholar

Lowe P, Kovacs G, Howlett D. Incidence of polycystic ovaries and polycystic ovarian syndrome in women in Melbourne, Australia. Aust New Zeal J Obstet Gynaecol. 2005;45(1):17–9. https://doi.org/10.1111/j.1479-828X.2005.00334.x.

Article Google Scholar

Akram M, Roohi N. Endocrine correlates of polycystic ovary syndrome in Pakistani women. J Coll Doctors Surg Pakistan. 2015;25(1):22-6.

google scholar

Stein IF, Leventhal ML. Amenorrhea is associated with bilateral polycystic ovaries. Ben J Obstet Gynecol. 1935;29(2):181-91. https://doi.org/10.1016/j.ajog.2015.12.013.

Article Google Scholar

Fauser BCJM. Revised 2003 consensus on diagnostic criteria and long-term health risks associated with polycystic ovary syndrome. Fertile Sterile. 2004;81(1):19-25. https://doi.org/10.1016/j.fertnstert.2003.10.004.

Article Google Scholar

Sobti S, Dewan R, Ranga S. Metabolic syndrome and insulin resistance in PCOS phenotypes. Int J Reprod Contraception Obstet Gynecol. 2017;6(11):5067. https://doi.org/10.18203/2320-1770.ijrcog20175027.

Article Google Scholar

Kar S. Anthropometric, clinical and metabolic comparisons of the four Rotterdam PCOS phenotypes: a prospective study of PCOS women. J Hum Reprod Sci. 2013;6(3):194–200. https://doi.org/10.4103/0974-1208.121422.

Article PubMed PubMed Central Google Scholar

Lauritsen MP, Svendsen PF, Andersen AN. Diagnostic criteria for polycystic ovary syndrome. Ugeskr Laeger. 2019; 181 (15): 671–9. https://doi.org/10.1016/S1701-2163(16)32915-2.

Article Google Scholar

Dunaif A, Segal KR, Futterweit W, Dobrjansky A. Profound peripheral insulin resistance, independent of obesity, in polycystic ovarian syndrome. Diabetes mellitus. 1989;38(9):1165–74. https://doi.org/10.2337/diab.38.9.1165.

CAS article PubMed Google Scholar

Paul C, Lagana AS, Maniglio P, Triolo O, Brady DM. The synergistic action of inositol and other nutraceuticals counteracts insulin resistance in polycystic ovary syndrome and metabolic syndrome: state-of-the-art and future perspectives. Gynaecol Endocrinol. 2016;32(6):431–8. https://doi.org/10.3109/09513590.2016.1144741.

CAS article PubMed Google Scholar

D’Alterio MN, Sigilli M, Succu AG, Ghisu V, Laganà AS, Sorrentino F, Nappi L, Tinelli R, Angioni S. Pregnancy outcomes in women with polycystic ovarian syndrome. Minerva Obstet Gynecol. 2022; 74(1): 45-59. https://doi.org/10.23736/S2724-606X.21.04758-4.

Article PubMed Google Scholar

Legro RS, Arslanian SA, Ehrmann DA, Hoeger KM, Murad MH, Pasquali R, et al. Diagnosis and treatment of polycystic ovary syndrome: a clinical practice guideline for the endocrine society. J Clin Endocrinol Metab. 2013;98(12):4565–92. https://doi.org/10.1210/jc.2013-2350.

CAS article PubMed PubMed Central Google Scholar

Tsilchorozidou T, Overton C, Conway GS. The pathophysiology of polycystic ovary syndrome. Clin Endocrinol. 2004;60:1–17. https://doi.org/10.1046/j.1365-2265.2003.01842.x.

CAS article Google Scholar

Dewailly D, Andersen CY, Balen A, Broekmans F, Dilaver N, Fanchin R, Griesinger G, Kelsey TW, La Marca A, Lambbalk C, Mason H, Nelson SM, Visser JA, Wallace WH, Anderson RA. The physiology and clinical utility of anti-Müller hormone in women. Hum Reprod update. 2014;20(3):370-85. https://doi.org/10.1093/humupd/dmt062.

Article PubMed Google Scholar

Casadei L, Madrigale A, Puca F, Manicuti C, Emidi E, Piccione E, Dewailly D. Role of serum anti-Müllerian hormone (AMH) in the hormonal diagnosis of polycystic ovary syndrome. Gynaecol Endocrinol. 2013;29(6):545–50. https://doi.org/10.3109/09513590.2013.777415.

CAS article PubMed Google Scholar

Sahmay S, Aydin Y, Oncul M, Senturk LM. Diagnosis of polycystic ovary syndrome: AMH in combination with clinical signs. J Assist Reprod Genet. 2014;31(2):213–20. https://doi.org/10.1007/s10815-013-0149-0.

Article PubMed Google Scholar

Di Paola R, Garzon S, Giuliani S, Laganà AS, Noventa M, Parissone F, Zorzi C, Raffaelli R, Ghezzi F, Franchi M, Zaffagnini S. Do we choose the appropriate FSH starting dose during controlled ovarian stimulation for intrauterine insemination cycles ? Possible application of a nomogram based on the woman’s age and markers of ovarian reserve. Arch Gynaecol Obst. 2018;298(5):1029–35. https://doi.org/10.1007/s00404-018-4906-2.

CAS article Google Scholar

Dewailly D, Gronier H, Poncelet E, Robin G, Leroy M, Pigny P, et al. Diagnosis of Polycystic Ovarian Syndrome (PCOS): Reviewing Thresholds of Follicle Number on Ultrasound and Serum AMH Level for the definition of polycystic ovaries. Hum Fig. 2011;26(11):3123–9. https://doi.org/10.1093/humrep/der297.

CAS article PubMed Google Scholar

Mohammad MB, Seghinsara AM. Polycystic ovary syndrome (PCOS), diagnostic criteria and AMH. Asian Pac J Cancer Previous. 2017;18(1):17–21. https://doi.org/10.22034/APJCP.2017.18.1.17.

Article PubMed Central Google Scholar

Balen AH, Laven JSE, Tan SL, Dewailly D. Ultrasound of the polycystic ovary: international consensus definitions. Hum Reprod update. 2003;9(6):505–14. https://doi.org/10.1093/humupd/dmg044.

Article PubMed Google Scholar

Akram M, Roohi N. Endocrine correlates of polycystic ovary syndrome in Pakistani women. J Coll Phys Surg Pak. 2015;25(1):22-6.

google scholar

Hatch R, Rosenfield RL, Kim MH, Tredway D. Hirsutism: implications, etiology and management. Ben J Obstet Gynecol. 1981;140(7):815–30. https://doi.org/10.1016/0002-9378(81)90746-8.

CAS article PubMed Google Scholar

World Medical Association. Declaration of the World Medical Association of Helsinki: Ethical Principles for Medical Research Involving Humans. J Am Coll Dent. 2014;81(3):14–8.

google scholar

Zhu R, Lee BH, Huang Z, Indran IR, Li J, Shen L, et al. Antimuller hormone, antral follicle count, and ovarian volume predict menstrual cycle length in healthy women. Clin Endocrinol. 2016;84(6):870–7. https://doi.org/10.1111/cen.12984.

CAS article Google Scholar

Nyboe Andersen A, Nelson SM, Fauser BCJM, García-Velasco JA, Klein BM, Arce JC, et al. Individualized versus conventional ovarian stimulation for in vitro fertilization: a multicenter, randomized, controlled, rater-blinded, phase 3 non- inferiority study. Fertile Sterile. 2017;107(2):387-96. https://doi.org/10.1016/j.fertnstert.2016.10.033.

CAS article PubMed Google Scholar

Sova H, Unkila-Kallio L, Tiitinen A, Hippeläinen M, Perheentupa A, Tinkanen H, et al. Hormone profiling, including anti-Müller hormone (AMH), for the diagnosis of polycystic ovary syndrome (PCOS) and characterization of PCOS phenotypes . Gynaecol Endocrinol. 2019;35(7):595-600. https://doi.org/10.1080/09513590.2018.1559807.

CAS article PubMed Google Scholar

Van Disseldorp J, Lambbalk CB, Kwee J, Looman CWN, Eijkemans MJC, Fauser BC, et al. Comparison of inter- and intracyclic variability of anti-Müllerian hormone and antral follicle counts. Hum Fig. 2010;25(1):221–7. https://doi.org/10.1093/humrep/dep366.

Article PubMed Google Scholar

Abbara A, Eng PC, Phylactou M, Clarke SA, Hunjan T, Roberts R, et al. Anti-müller hormone (AMH) in the diagnosis of menstrual disorders due to polycystic ovarian syndrome. Anterior endocrinol. 2019;10:656. https://doi.org/10.3389/fendo.2019.0656.

Article Google Scholar

Noweir MH, Bafail AO. Study of summer heat exposure in the ground services of a major international airport in Saudi Arabia. Assess environmental monitor. 2008;145(1–3):103–11. https://doi.org/10.1007/s10661-007-0019-2.

Article PubMed Google Scholar

Azziz R, Carmina E, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale HF, Futterweit W, et al. The Androgen Excess and PCOS Society Criteria for Polycystic Ovarian Syndrome: The Complete Task Group Report. Fertile Sterile. 2009;91(2):456–88. https://doi.org/10.1016/j.fertnstert.2008.06.035.

Article PubMed Google Scholar

Carlsen SM, Vanky E, Fleming R. Anti-Müllerian hormone concentrations in androgen-suppressed women with polycystic ovarian syndrome. Hum Fig. 2009;24(7):1732–8. https://doi.org/10.1093/humrep/dep074.

CAS article PubMed Google Scholar

Teede H, Misso M, Tassone EC, Dewailly D, Ng EH, Azziz R, et al. Anti-Müller hormone in PCOS: a review informing international guidelines. Trends Endocrinol Metab. 2019;30(7):467–8. https://doi.org/10.1016/j.tem.2019.04.006.

CAS article PubMed Google Scholar

Barthelmess EK, Naz RK. Polycystic ovary syndrome: current status and future perspective. Front Cinema. 2014;6(1):104-19. https://doi.org/10.2741/e695.

Article Google Scholar

Chen ZJ, Zhao H, He L, Shi Y, Qin Y, Shi Y, et al. Genome-wide association study identifies susceptibility loci for polycystic ovary syndrome on chromosome 2p16.3, 2p21, and 9q33.3. Nat Genet. 2011;43(1):55–9. https://doi.org/10.1038/ng.732.

CAS article PubMed Google Scholar